angiogenesis inhibitors (Searle)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameangiogenesis inhibitors (Searle)
Drug Alias NameCOX-2 inhibitors (Searle)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsAngiogenesis disorderNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A